{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:47:29Z","timestamp":1775040449875,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302491"],"award-info":[{"award-number":["82302491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130052"],"award-info":[{"award-number":["82130052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-026-01548-5","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:58:18Z","timestamp":1772099898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP30-AS1 functions as a post-transcriptional amplifier of interferon signalling to drive autoimmune pathogenesis"],"prefix":"10.1186","volume":"16","author":[{"given":"Jie","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Peng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"1","key":"1548_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36\u201349. https:\/\/doi.org\/10.1038\/nri3581.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1548_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87\u2013103. https:\/\/doi.org\/10.1038\/nri3787.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1548_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nri.2016.78","volume":"16","author":"M Schlee","year":"2016","unstructured":"Schlee M, Hartmann G. Discriminating self from non-self in nucleic acid sensing. Nat Rev Immunol. 2016;16(9):566\u201380. https:\/\/doi.org\/10.1038\/nri.2016.78.","journal-title":"Nat Rev Immunol"},{"issue":"6121","key":"1548_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786\u201391. https:\/\/doi.org\/10.1126\/science.1232458.","journal-title":"Science"},{"issue":"3","key":"1548_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.2229","volume":"13","author":"N Yan","year":"2012","unstructured":"Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat Immunol. 2012;13(3):214\u201322. https:\/\/doi.org\/10.1038\/ni.2229.","journal-title":"Nat Immunol"},{"key":"1548_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513\u201345. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120231.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1548_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","volume":"36","author":"GR Stark","year":"2012","unstructured":"Stark GR, Darnell JE. Jr. The JAK-STAT pathway at Twenty. Immunity. 2012;36(4):503\u2013. https:\/\/doi.org\/10.1016\/j.immuni.2012.03.013. \u200914.","journal-title":"Immunity"},{"issue":"1","key":"1548_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13578-023-01188-z","volume":"13","author":"L Ji","year":"2023","unstructured":"Ji L, Li T, Chen H, Yang Y, Lu E, Liu J, et al. The crucial regulatory role of type I interferon in inflammatory diseases. Cell Biosci. 2023;13(1):230. https:\/\/doi.org\/10.1186\/s13578-023-01188-z.","journal-title":"Cell Biosci"},{"issue":"9","key":"1548_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3899\/jrheum.2022-0827","volume":"50","author":"AC Londe","year":"2023","unstructured":"Londe AC, Fernandez-Ruiz R, Julio PR, Appenzeller S, Niewold TB. Type I interferons in autoimmunity: implications in clinical phenotypes and treatment response. J Rheumatol. 2023;50(9):1103\u201313. https:\/\/doi.org\/10.3899\/jrheum.2022-0827.","journal-title":"J Rheumatol"},{"issue":"8","key":"1548_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","volume":"22","author":"YJ Crow","year":"2022","unstructured":"Crow YJ, Stetson DB. The type I interferonopathies: 10 years on. Nat Rev Immunol. 2022;22(8):471. https:\/\/doi.org\/10.1038\/s41577-021-00633-9","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1548_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","volume":"14","author":"MK Crow","year":"2019","unstructured":"Crow MK, Olferiev M, Kirou KA. Type I interferons in autoimmune disease. Annu Rev Pathol. 2019;14(1):369\u201393.","journal-title":"Annu Rev Pathol"},{"issue":"Suppl 1","key":"1548_CR12","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar2885","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA. Type 1 interferons and myositis. Arthritis Res Ther. 2010;12(Suppl 1):S4. https:\/\/doi.org\/10.1186\/ar2885.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1548_CR13","doi-asserted-by":"publisher","first-page":"e000270","DOI":"10.1136\/lupus-2018-000270","volume":"6","author":"L Ronnblom","year":"2019","unstructured":"Ronnblom L, Leonard D. Interferon pathway in SLE: one key to unlocking the mystery of the disease. Lupus Sci Med. 2019;6(1):e000270. https:\/\/doi.org\/10.1136\/lupus-2018-000270.","journal-title":"Lupus Sci Med"},{"issue":"2","key":"1548_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11926-023-01125-6","volume":"26","author":"CMA Lin","year":"2024","unstructured":"Lin CMA, Isaacs JD, Cooles FAH. Role of IFN-alpha in rheumatoid arthritis. Curr Rheumatol Rep. 2024;26(2):37\u201352. https:\/\/doi.org\/10.1007\/s11926-023-01125-6.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"1548_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","volume":"25","author":"J Banchereau","year":"2006","unstructured":"Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25(3):383 https:\/\/doi.org\/10.1016\/j.immuni.2006.08.010","journal-title":"Immunity"},{"issue":"11","key":"1548_CR16","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.4049\/jimmunol.2000596","volume":"205","author":"JL Turnier","year":"2020","unstructured":"Turnier JL, Kahlenberg JM. The role of cutaneous type I IFNs in autoimmune and autoinflammatory diseases. J Immunol. 2020;205(11):2941\u201350. https:\/\/doi.org\/10.4049\/jimmunol.2000596.","journal-title":"J Immunol"},{"issue":"7","key":"1548_CR17","doi-asserted-by":"publisher","first-page":"mjae029","DOI":"10.1093\/jmcb\/mjae029","volume":"16","author":"J Li","year":"2024","unstructured":"Li J, Zhu J, Yang H, Hou F Sterile activation of RNA-sensing pathways in autoimmunity. J Mol Cell Biol. 2024;16(7):mjae029. https:\/\/doi.org\/10.1093\/jmcb\/mjae029.","journal-title":"J Mol Cell Biol"},{"key":"1548_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","volume":"19","author":"T Taniguchi","year":"2001","unstructured":"Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001;19:623\u201355. https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.623.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1548_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","volume":"36","author":"JJ O\u2019Shea","year":"2012","unstructured":"O\u2019Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012;36(4):542\u201350. https:\/\/doi.org\/10.1016\/j.immuni.2012.03.014.","journal-title":"Immunity"},{"issue":"6","key":"1548_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2884","volume":"15","author":"P Kafasla","year":"2014","unstructured":"Kafasla P, Skliris A, Kontoyiannis DL. Post-transcriptional coordination of immunological responses by RNA-binding proteins. Nat Immunol. 2014;15(6):492\u2013502. https:\/\/doi.org\/10.1038\/ni.2884.","journal-title":"Nat Immunol"},{"issue":"1","key":"1548_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri2685","volume":"10","author":"P Anderson","year":"2010","unstructured":"Anderson P. Post-transcriptional Regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol. 2010;10(1):24\u201335. https:\/\/doi.org\/10.1038\/nri2685.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"1548_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tibs.2025.04.004","volume":"50","author":"A Panthi","year":"2025","unstructured":"Panthi A, Lynch KW. RNA processing in innate immunity: regulation by RNA-binding proteins. Trends Biochem Sci. 2025;50(7):610\u201321. https:\/\/doi.org\/10.1016\/j.tibs.2025.04.004.","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"1548_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ni1584","volume":"9","author":"P Anderson","year":"2008","unstructured":"Anderson P. Post-transcriptional control of cytokine production. Nat Immunol. 2008;9(4):353\u20139. https:\/\/doi.org\/10.1038\/ni1584.","journal-title":"Nat Immunol"},{"issue":"4","key":"1548_CR24","doi-asserted-by":"publisher","first-page":"194419","DOI":"10.1016\/j.bbagrm.2019.194419","volume":"1863","author":"EK Robinson","year":"2020","unstructured":"Robinson EK, Covarrubias S, Carpenter S. The how and why of LncRNA function: an innate immune perspective. Biochim Biophys Acta Gene Regul Mech. 2020;1863(4):194419. https:\/\/doi.org\/10.1016\/j.bbagrm.2019.194419.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"1548_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.virusres.2015.09.023","volume":"212","author":"S Valadkhan","year":"2016","unstructured":"Valadkhan S, Gunawardane LS. lncRNA-mediated regulation of the interferon response. Virus Res. 2016;212:127\u201336. https:\/\/doi.org\/10.1016\/j.virusres.2015.09.023.","journal-title":"Virus Res"},{"key":"1548_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145\u201366. https:\/\/doi.org\/10.1146\/annurev-biochem-051410-092902.","journal-title":"Annu Rev Biochem"},{"key":"1548_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-immunol-041015-055459","volume":"35","author":"MK Atianand","year":"2017","unstructured":"Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology of long noncoding RNAs. Annu Rev Immunol. 2017;35:177\u201398. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055459","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1548_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"1548_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tibs.2016.07.003","volume":"41","author":"LL Chen","year":"2016","unstructured":"Chen LL. Linking long noncoding RNA localization and function. Trends Biochem Sci. 2016;41(9):761\u2013. https:\/\/doi.org\/10.1016\/j.tibs.2016.07.003. \u200972.","journal-title":"Trends Biochem Sci"},{"issue":"16","key":"1548_CR30","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1093\/nar\/gku713","volume":"42","author":"H Kambara","year":"2014","unstructured":"Kambara H, Niazi F, Kostadinova L, Moonka DK, Siegel CT, Post AB, et al. Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res. 2014;42(16):10668\u201380. https:\/\/doi.org\/10.1093\/nar\/gku713.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1548_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.it.2014.07.005","volume":"35","author":"JA Heward","year":"2014","unstructured":"Heward JA, Lindsay MA. Long non-coding RNAs in the regulation of the immune response. Trends Immunol. 2014;35(9):408\u201319. https:\/\/doi.org\/10.1016\/j.it.2014.07.005.","journal-title":"Trends Immunol"},{"issue":"12","key":"1548_CR32","doi-asserted-by":"publisher","first-page":"e2004086","DOI":"10.1371\/journal.pbio.2004086","volume":"15","author":"AE Shaw","year":"2017","unstructured":"Shaw AE, Hughes J, Gu Q, Behdenna A, Singer JB, Dennis T, et al. Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses. PLoS Biol. 2017;15(12):e2004086. https:\/\/doi.org\/10.1371\/journal.pbio.2004086.","journal-title":"PLoS Biol"},{"key":"1548_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fmolb.2017.00071","volume":"4","author":"SM Garcia-Maurino","year":"2017","unstructured":"Garcia-Maurino SM, Rivero-Rodriguez F, Velazquez-Cruz A, Hernandez-Vellisca M, Diaz-Quintana A, De la Rosa MA, Diaz-Moreno I. RNA binding protein regulation and Cross-Talk in the control of AU-rich mRNA fate. Front Mol Biosci. 2017;4:71. https:\/\/doi.org\/10.3389\/fmolb.2017.00071.","journal-title":"Front Mol Biosci"},{"issue":"22","key":"1548_CR34","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1093\/nar\/gki1012","volume":"33","author":"C Barreau","year":"2005","unstructured":"Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 2005;33(22):7138\u201350. https:\/\/doi.org\/10.1093\/nar\/gki1012.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1548_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/v16030468","volume":"16","author":"D Khan","year":"2024","unstructured":"Khan D, Fox PL. Host-like RNA elements regulate virus translation. Viruses. 2024;16(3):468. https:\/\/doi.org\/10.3390\/v16030468","journal-title":"Viruses"},{"issue":"3","key":"1548_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165(3):551\u201365. https:\/\/doi.org\/10.1016\/j.cell.2016.03.008.","journal-title":"Cell"},{"issue":"3","key":"1548_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/art.39950","volume":"69","author":"RW Hoffman","year":"2017","unstructured":"Hoffman RW, Merrill JT, Alarcon-Riquelme MM, Petri M, Dow ER, Nantz E, et al. Gene expression and pharmacodynamic changes in 1,760 systemic lupus erythematosus patients from two phase III trials of BAFF Blockade with tabalumab. Arthritis Rheumatol. 2017;69(3):643\u201354. https:\/\/doi.org\/10.1002\/art.39950.","journal-title":"Arthritis Rheumatol"},{"issue":"6259","key":"1548_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.aac7442","volume":"350","author":"T Hung","year":"2015","unstructured":"Hung T, Pratt GA, Sundararaman B, Townsend MJ, Chaivorapol C, Bhangale T, et al. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science. 2015;350(6259):455\u20139. https:\/\/doi.org\/10.1126\/science.aac7442.","journal-title":"Science"},{"issue":"11","key":"1548_CR39","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.4049\/jimmunol.1601988","volume":"198","author":"Y Guo","year":"2017","unstructured":"Guo Y, Walsh AM, Fearon U, Smith MD, Wechalekar MD, Yin X, et al. CD40L-Dependent pathway is active at various stages of rheumatoid arthritis disease progression. J Immunol. 2017;198(11):4490\u2013501. https:\/\/doi.org\/10.4049\/jimmunol.1601988.","journal-title":"J Immunol"},{"issue":"1","key":"1548_CR40","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/s41467-018-05044-4","volume":"9","author":"S Tasaki","year":"2018","unstructured":"Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, et al. Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. Nat Commun. 2018;9(1):2755. https:\/\/doi.org\/10.1038\/s41467-018-05044-4.","journal-title":"Nat Commun"},{"issue":"8","key":"1548_CR41","doi-asserted-by":"publisher","first-page":"101130","DOI":"10.1016\/j.xcrm.2023.101130","volume":"4","author":"MM Xie","year":"2023","unstructured":"Xie MM, Dai B, Hackney JA, Sun T, Zhang J, Jackman JK, et al. An agonistic anti-signal regulatory protein \u03b1 antibody for chronic inflammatory diseases. Cell Rep Med. 2023;4(8):101130. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101130.","journal-title":"Cell Rep Med"},{"issue":"3","key":"1548_CR42","doi-asserted-by":"publisher","first-page":"e134189","DOI":"10.1172\/jci.insight.134189","volume":"5","author":"N Seto","year":"2020","unstructured":"Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, et al Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight. 2020;5(3):e134189. https:\/\/doi.org\/10.1172\/jci.insight.134189.","journal-title":"JCI Insight"},{"issue":"16","key":"1548_CR43","doi-asserted-by":"publisher","first-page":"e139558","DOI":"10.1172\/jci.insight.139558","volume":"5","author":"LC Tsoi","year":"2020","unstructured":"Tsoi LC, Gharaee-Kermani M, Berthier CC, Nault T, Hile GA, Estadt SN, et al IL18-containing 5-gene signature distinguishes histologically identical dermatomyositis and lupus erythematosus skin lesions. JCI Insight. 2020;5(16):e139558. https:\/\/doi.org\/10.1172\/jci.insight.139558.","journal-title":"JCI Insight"},{"issue":"2","key":"1548_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","volume":"36","author":"DJ Gough","year":"2012","unstructured":"Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity. 2012;36(2):166\u201374. https:\/\/doi.org\/10.1016\/j.immuni.2012.01.011.","journal-title":"Immunity"},{"issue":"12","key":"1548_CR45","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1084\/jem.20161596","volume":"213","author":"MP Rodero","year":"2016","unstructured":"Rodero MP, Crow YJ. Type I interferon-mediated Monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016;213(12):2527\u201338. https:\/\/doi.org\/10.1084\/jem.20161596.","journal-title":"J Exp Med"},{"issue":"10","key":"1548_CR46","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/jem.20101664","volume":"207","author":"G Trinchieri","year":"2010","unstructured":"Trinchieri G. Type I interferon: friend or foe? J Exp Med. 2010;207(10):2053\u201363. https:\/\/doi.org\/10.1084\/jem.20101664.","journal-title":"J Exp Med"},{"issue":"3","key":"1548_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.it.2015.02.002","volume":"36","author":"RA Porritt","year":"2015","unstructured":"Porritt RA, Hertzog PJ. Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol. 2015;36(3):150\u201360. https:\/\/doi.org\/10.1016\/j.it.2015.02.002.","journal-title":"Trends Immunol"},{"issue":"17","key":"1548_CR48","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s00018-010-0383-x","volume":"67","author":"KS Khabar","year":"2010","unstructured":"Khabar KS. Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci. 2010;67(17):2937\u201355. https:\/\/doi.org\/10.1007\/s00018-010-0383-x.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1548_CR49","doi-asserted-by":"publisher","first-page":"e1004368","DOI":"10.1371\/journal.pgen.1004368","volume":"10","author":"J Schott","year":"2014","unstructured":"Schott J, Reitter S, Philipp J, Haneke K, Schafer H, Stoecklin G. Translational regulation of specific mRNAs controls feedback Inhibition and survival during macrophage activation. PLoS Genet. 2014;10(6):e1004368. https:\/\/doi.org\/10.1371\/journal.pgen.1004368.","journal-title":"PLoS Genet"},{"issue":"1","key":"1548_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2005.25.1","volume":"25","author":"KS Khabar","year":"2005","unstructured":"Khabar KS. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J Interferon Cytokine Res. 2005;25(1):1\u201310. https:\/\/doi.org\/10.1089\/jir.2005.25.1.","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"1548_CR51","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1182\/blood-2005-07-3058","volume":"107","author":"I Sauer","year":"2006","unstructured":"Sauer I, Schaljo B, Vogl C, Gattermeier I, Kolbe T, Muller M, et al. Interferons limit inflammatory responses by induction of tristetraprolin. Blood. 2006;107(12):4790. https:\/\/doi.org\/10.1182\/blood-2005-07-3058","journal-title":"Blood"},{"issue":"3","key":"1548_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","volume":"25","author":"DB Stetson","year":"2006","unstructured":"Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity. 2006;25(3):373\u201381. https:\/\/doi.org\/10.1016\/j.immuni.2006.08.007.","journal-title":"Immunity"},{"issue":"1","key":"1548_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"13","author":"MS Diamond","year":"2013","unstructured":"Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013;13(1):46\u201357. https:\/\/doi.org\/10.1038\/nri3344.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"1548_CR54","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ni.2048","volume":"12","author":"A Pichlmair","year":"2011","unstructured":"Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, Burkard TR, et al. IFIT1 is an antiviral protein that recognizes 5\u2019-triphosphate RNA. Nat Immunol. 2011;12(7):624\u201330. https:\/\/doi.org\/10.1038\/ni.2048.","journal-title":"Nat Immunol"},{"issue":"1","key":"1548_CR55","doi-asserted-by":"publisher","first-page":"e1012854","DOI":"10.1371\/journal.ppat.1012854","volume":"21","author":"Y Cao","year":"2025","unstructured":"Cao Y, Chin AWH, Gu H, Li M, Gu Y, Lau SPN, et al. An interferon-stimulated long non-coding RNA USP30-AS1 as an immune modulator in influenza A virus infection. PLoS Pathog. 2025;21(1):e1012854. https:\/\/doi.org\/10.1371\/journal.ppat.1012854.","journal-title":"PLoS Pathog"},{"issue":"1","key":"1548_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3892\/ol.2021.12766","volume":"22","author":"M Chen","year":"2021","unstructured":"Chen M, Chi Y, Chen H, Zhao L. Long non-coding RNA USP30-AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA-299-3p and thereby overexpressing PTP4A1. Oncol Lett. 2021;22(1):505. https:\/\/doi.org\/10.3892\/ol.2021.12766.","journal-title":"Oncol Lett"},{"issue":"1","key":"1548_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12957-022-02529-x","volume":"20","author":"C Li","year":"2022","unstructured":"Li C, Liang X, Liu Y. LncRNA USP30-AS1 sponges miR-765 and modulates the progression of colon cancer. World J Surg Oncol. 2022;20(1):73. https:\/\/doi.org\/10.1186\/s12957-022-02529-x.","journal-title":"World J Surg Oncol"},{"issue":"17","key":"1548_CR58","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3390\/cancers16172940","volume":"16","author":"E \u00c7akan","year":"2024","unstructured":"\u00c7akan E, Lara OD, Szymanowska A, Bayraktar E, Chavez-Reyes A, Lopez-Berestein G, et al Therapeutic antisense oligonucleotides in oncology: from bench to bedside. Cancers (Basel). 2024;16(17):2940. https:\/\/doi.org\/10.3390\/cancers16172940.","journal-title":"Cancers (Basel)"},{"key":"1548_CR59","doi-asserted-by":"publisher","first-page":"6663816","DOI":"10.1155\/ijcb\/6663816","volume":"2025","author":"MS Bhakta-Yadav","year":"2025","unstructured":"Bhakta-Yadav MS, Brown TL. Important aspects of siRNA design for optimal efficacy in vitro and in vivo. Int J Cell Biol. 2025;2025:6663816. https:\/\/doi.org\/10.1155\/ijcb\/6663816","journal-title":"Int J Cell Biol"},{"issue":"4","key":"1548_CR60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1261\/rna.079507.122","volume":"29","author":"SF Dowdy","year":"2023","unstructured":"Dowdy SF. Endosomal escape of RNA therapeutics: how do we solve this rate-limiting problem? RNA. 2023;29(4):396\u2013401. https:\/\/doi.org\/10.1261\/rna.079507.122.","journal-title":"RNA"},{"issue":"14","key":"1548_CR61","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1093\/nar\/gkw236","volume":"44","author":"RL Juliano","year":"2016","unstructured":"Juliano RL. The delivery of therapeutic oligonucleotides. Nucleic Acids Res. 2016;44(14):6518\u201348. https:\/\/doi.org\/10.1093\/nar\/gkw236.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1548_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/nat.2022.0061","volume":"33","author":"A Goyenvalle","year":"2023","unstructured":"Goyenvalle A, Jimenez-Mallebrera C, van Roon W, Sewing S, Krieg AM, Arechavala-Gomeza V, Andersson P. Considerations in the preclinical assessment of the safety of antisense oligonucleotides. Nucleic Acid Ther. 2023;33(1):1\u201316. https:\/\/doi.org\/10.1089\/nat.2022.0061.","journal-title":"Nucleic Acid Ther"},{"issue":"9","key":"1548_CR63","doi-asserted-by":"publisher","first-page":"13993","DOI":"10.1021\/acsnano.1c05099","volume":"15","author":"JP Bost","year":"2021","unstructured":"Bost JP, Barriga H, Holme MN, Gallud A, Maugeri M, Gupta D, et al. Delivery of oligonucleotide therapeutics: chemical Modifications, lipid Nanoparticles, and extracellular vesicles. ACS Nano. 2021;15(9):13993\u20134021. https:\/\/doi.org\/10.1021\/acsnano.1c05099.","journal-title":"ACS Nano"},{"issue":"38","key":"1548_CR64","doi-asserted-by":"publisher","first-page":"e2407115","DOI":"10.1002\/adma.202407115","volume":"36","author":"Z Pan","year":"2024","unstructured":"Pan Z, Xu K, Huang G, Hu H, Yang H, Shen H, et al. Pyroptotic-Spatiotemporally selective delivery of SiRNA against pyroptosis and autoimmune diseases. Adv Mater. 2024;36(38):e2407115. https:\/\/doi.org\/10.1002\/adma.202407115.","journal-title":"Adv Mater"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-026-01548-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:46:20Z","timestamp":1775033180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-026-01548-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1186\/s13578-026-01548-5","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures of PBMCs isolation were approved by the Ethics Committee of Jiaxing Central Blood Station.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}